Matthew Price, M.D., Director of the Cardiac Catheterization Laboratory at Scripps Clinic, is Assistant Professor at STSI. He is certified by the American Board of Internal Medicine in internal medicine, cardiovascular disease, and interventional cardiology.
“The timing has emerged for individualized medicine, tailoring our drugs for the particular patient based on their genes,” he has said.
His clinical and research focus includes high-risk percutaneous coronary intervention (PCI), interventional approaches to congenital and structural heart disease, and anti-platelet therapy. Dr Price helps to lead several clinical trials examining the effectiveness of anti-platelet therapy and is the principal investigator of GRAVITAS, a randomized clinical trial to examine the safety and efficacy of individualized thienopyrdine therapy after PCI. He serves as an ad hoc reviewer for Circulation, the Journal of the American College of Cardiology and several of scientific journals.
After graduating from Cornell University with Distinction in All Subjects, he earned the M.D. degree at the University of California, Los Angeles School of Medicine and completed his internship and residency in internal medicine at the UCLA Center for Health Sciences. He subsequently completed a fellowship in cardiovascular diseases at Cedars-Sinai Medical Center where he served as Chief Fellow. He completed his training in interventional cardiology at Scripps Clinic.